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1. Introduction 
Earlier reports [ 1,2] have demonstrated the 
presence of a pyruvate carrier in rat liver mitochondria. 
The evidence was pH dependence of uptake and efflux 
of pyruvate suggesting exchange with hydroxide 
anions, saturation kinetics and the existence of a 
specific inhibitor, cw-cyano4-hydroxy-cinnamic acid. 
It was reported that phosphate and citrate anions 
would not exchange for pyruvate [l] but later there 
has been disagreement as to whether dicarboxylate 
anions could exchange with pyruvate across fhe 
mitochondrial membrane (cf. [3,4] ). Because of this 
and because of the potential relevance of pyruvate/ 
dicarboxylate exchange to the regulation of gluconeo- 
genesis we have reinvestigated this point using a 
recently published technique [S] . This technique, 
which uses cu-cyano-3-hydroxy-cinnamic acid as an 
‘inhibitor-stop’, has the merit (in comparison with 
other methods) of measuring initial rates of uptake 
along a controlled pH gradient at temperatures near 
to physiological. Our results suggest hat such a 
pyruvate/dicarboxylate exchange does occur and 
that it probably involves the pyruvate carrier only. 
Using the same technique we have also investigated 
the possibility suggested by others [6-81 that 
glucagon stimulation of gluconeogenesis in the liver 
in situ or in liver cells incubated in vitro may involve 
stimulation of pyruvate entry into the mitochondria. 
The suggestion was based on indirect evidence, 
namely increased rates of pyruvate decarboxylation 
and carboxylation by isolated mitochondria from 
liver exposed to high concentrations of glucagon. We 
have no shown directly that there is in fact a con- 
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comitant stimulation of initial pyruvate transport rate. 
Furthermore this effect does not depend on prior 
accumulation of dicarboxylate anions within the 
mitochondria. This is relevant because accumulation 
of dicarboxylate anions in liver mitochondria after 
glucagon injection into rats has been reported [9]. 
2. Methods and materials 
Methods of preparation of mitochondria and for 
studying uptake and efflux of pyruvate by mito- 
chondria were as in our earlier publication [5]. Two 
types of mitochondrial incubation media were used 
in the present work: Medium 1 contained 250 mM 
sucrose, 5’mM Hepes, 1 mM EGTA, 3 mM ascorbate, 
0.05 mM tetramethyl-phenylenediamine, 5 I.cg/ml 
rotenone and 1 pg/ml antimycin A. Medium 2 con- 
tained 125 mM KCl, 20 mM Hepes, 2 mM MgC12, 
2 mM arsenite, 5 I.cg/ml rotenone, 1 /.tg/ml antimycin 
A and ascorbate/tetramethylphenylenediamine as
above. The pH of both media was 7. Additions to 
media are indicated in tables and legends. Mito- 
chondrial pH gradient and membrane potential were 
determined by published methods [lo]. The possibi- 
lity of significant loss of pyruvate during mito- 
chondrial uptake or efflux experiments or transforma- 
tion of malate to pyruvate when the former ion was 
present was tested by incubating mitochondria in the 
medium used in these studies with addition of 1 mM 
pyruvate or malate. After 5 min the mitochondrial 
protein was precipitated with 2% perchloric acid and 
pyruvate was assayed [ 111. 
45 
Volume 63, number 1 FEBS LETTERS March 1976 
For experiments involving glucagon injection a 
matched pair of rats was used for an experiment on a 
single day. After anaesthetization with ether and 
nembutal(60 mg/kg i.p.) and a further 20 min the 
rats were injected i.p. with either saline or glucagon 
and after an additional 30 min blood was sampled 
from the tail vein. The animal was killed by cutting 
the neck vessels and the liver removed. Measurement 
of the rates of [ 1 -r4C] pyruvate decarboxylation was 
as described by Adam and Haynes [6]. 
Plasma glucose was measured by glucose oxidase 
kit (Boehringer, London). 
Glucagon was from Eli Lilly, Basingstoke, U.K. 
Nembutal was from Abbott Laboratories Ltd., 
Queenborough, Kent, U.K. Sources of other materials 
were given earlier [5] . 
3. Results and discussion 
3.1. &uvate recovery 
Under the conditions used for experiments measur- 
ing pyruvate uptake or efflux there was no detectable 
loss of pyruvate during 5 min incubation of mito- 
chondria when 1 mM pyruvate was initially present 
nor gain of pyruvate when 1 mM malate was initially 
present (3 determinations, limit of detection 40 nmol 
per ml). In earlier work [5] no radioactivity from 
[2-r4C]pyruvate appeared in other mitochondrial 
metabolites. 
3.2. Rates of pyruvate uptake and eff2ux in various 
conditions 
Applying the usual concept of membrane carriers 
Table 1 
Effect of various anions on initial rates of [2-“‘Clpyruvate uptake by mitochondria 
Anion 
tested 
(K+ salts) 
Concentration of Concentration of 
tested anion in tested anion in 
preincubation incubation medium Initial rate as 
medium (mM) during (mM) after % of control for 
2 min before addition addition of each mitochondrial 
Procedure of [ 2-r4C] pyruvate [2-W] pyruvate preparation 
: 
1 1 27 f* 1 (3) 
Succinate 0 1 25 t* 8 (3) 
C 1 0.05 158 f* 4 (3) 
: 
1 1 36.0 ** 8.6 (3) 
Malate 0 1 26.4 t* 6 (4) 
C 1 0.05 132 f* 12 (5) 
a 1 1 57.8 ** 5.5 (4) 
Citrate b 0 1 82.9 ** 6.8 (3) 
C 1 0.05 91.5 i-* 2.4 (3) 
6 
1 1 41.7 ** 10.2 (3) 
Phosphate 0 1 33.0 ** 8.3 (3) 
C 1 0.05 84.9 i* 4.7 (3) 
For procedures a and b medium 2 was used for both incubations. Mitochondrial concentration was 
1 mg protein/ml in both cases. For procedure c medium 1 was used for preincubation and the 
mitochondrial concentration then was 20 mg/ml while medium 2 was used for incubation when 
mitochondrial concentration was 1 mg protein/ml. In every experiment we determined a control rate 
of [2-r4C]pyruvate uptake in the absence of all the other anions to be tested. 
The temperature of all media was 27°C. The control rate of pyruvate uptake averaged for all 
experiments was 27.52 t 1.55 [19] nmoles/mg protein/min. Numbers in brackets are numbers of 
mitochondrial preparations. 
*p <0.05 for % differences from control rates. 
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to the special case of the mitochondrial membrane one 
can predict that to establish that another anion travels 
on the pyruvate carrier we should (1) show competition 
by the anion for uptake of pyruvate (2) show counter- 
transport i.e. stimulation of pyruvate movement in 
one direction by movement of the other anion in the 
other direction (3) eliminate alternative explanations 
for the data e.g. effects on pH gradient or use of 
different carriers. Table 1 (procedures a and b) shows 
that exposure of mitochondria to succinate, malate, 
citrate or phosphate at a concentration of 1 mM before 
and/or during incubation with 1.4 mM [2-‘4C]pyruvate 
resulted in significant inhibition of initial rates of 
pyruvate uptake. However, results of procedure c in 
table 1 show that preincubation with one of the anions 
malate, succinate, phosphate or citrate at a concentra- 
tion of 1 mM followed by 20 times dilution of the 
anion during the period of exposure to [2-14C] 
pyruvate results in a clear distinction in the effects of 
the dicarboxylate anions from that of citrate or 
phosphate. Preincubation with dicarboxylate anions 
resulted in a significant stimulation of initial rate of 
[2-14C]pyruvate uptake whereas preincubation with 
citrate or phosphate anions still led to inhibition of 
initial rate of [2-14C]pyruvate uptake. Mowbray [3] 
has also noted stimulation of the rate of pyruvate 
uptake by the presence of low concentrations of 
malate in the incubation medium. We have attempted 
to determine how far alterations of mitochondrial 
pH gradient may account for the above results. We 
observed (data not shown) that pyruvate and malate 
anions each at a concentration of 1 mM did not 
disturb the mitochondrial pH gradient (or membrane 
potential) set up by the ascorbate/tetramethylphenyl- 
enediamine couple but there was a small decrease in 
the pH gradient due to the presence of 1 mM phosphate. 
However, such measurements made in the steady state 
do not exclude the possibility of a transient fall in the 
pH gradient on exposure to two permeant anions and 
hence inhibition of the anions uptake which depends 
on this gradient. It is possible therefore that the 
results of procedures a and b are at least partly 
explicable on the basis of just such a transient fall in 
the mitochondrial pH gradient. This may also occur 
to a smaller extent in the cases involving preincubation 
with citrate or phosphate in procedure c since the 
small quantity of these anions unavoidably carried 
over to the incubation medium may not be insignificant 
compared to the KM of the respective carriers. 
However, the stimulation of [2-14C] pyruvate uptake 
due to preincubation with the dicarboxylate anions 
could be an example of counter-transport of incoming 
pyruvate for previously accumulated malate or 
succinate. This interpretation is supported by the data 
of table 2 in which efflux of [2-14C]pyruvate from 
pre-loaded mitochondria was stimulated by external 
pyruvate, malate or oxaloacetate but not by citrate 
or phosphate anions at the same concentration. Since 
butylmalonate (an inhibitor of the dicarboxylate 
carrier; [ 12,131 did not prevent the effect of external 
pyruvate or malate we suggest hat the malate/ 
pyruvate exchange involved the pyruvate carrier only. 
Butylmalonate alone encouraged efflux of [2-14C] 
pyruvate but in view of its high concentration (10 mM) 
the effect was relatively slight. Mowbray [3] reported 
similar behaviour of butylmalonate in experiments on 
efflux of pyruvate from pre-loaded mitochondria. 
Since also a-cyano-3-hydroxycinnamic acid which is 
unlikely to block the dicarboxylate carrier [5] 
blocked the [2-‘4C]pyruvate/unlabelled pyruvate and 
[2-‘4C]pyruvate/malate xchanges we conclude that 
pyruvate anions are unable to utilize the dicarboxylate 
anion carrier. 
3.3. Effects of glucagon injection on pyruvate transport 
and decarboxylation by isolated mitochondria 
Experiment 1 in table 3 shows that glucagon pre- 
treatment of rats led to significant stimulation of the 
rate of production of 14C02 from [ 1-14C] pyruvate by 
isolated liver mitochondria. The effect is somewhat 
smaller than that reported by Adam and Haynes [6] 
as also the absolute values for the rates. Experiment 2 
shows that there is a concomitant and quantitatively 
similar stimulation of the initial rate of pyruvate 
uptake by the mitochondria. A possible mechanism 
for this latter effect might involve accumulation in 
vivo of counter ions in the mitochondrial matrix. One 
such counter-ion might be palmitoyl-1-carnitine due 
to mobilization of free fatty acids by glucagon. 
Mowbray [3] has shown that extra-mitochondrial 
DLpalmitoyl carnitine can encourage efflux of 
previously accumulated mitochondrial pyruvate. 
Another counter ion might be malate since Parilla et 
al. [9] have recently shown this ion to accumulate 
in the liver mitochondrial matrix after glucagon 
injection into rats. A third possible counter ion is 
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Table 2 
Effect of various anions on rate of [2-r4C]pyruvate fflux from mitochondria 
Anions added to 
incubation 
medium 
Pyruvate content 
of mitochondria 
at zero time 
(nmoles per mg 
of protein) 
Pyruvate content 
of mitochondria 
after 10 s 
incubation (nmoles 
per mg of protein) 
% of pyruvate 
remaining 
after 10 s 
None 
1 mM pyruvate 
1 mM pyruvate + 
10 mM ol-cyano-3- 
hydroxycinnamate 
10 mM cu-cyano-3- 
hydroxycinnamate 
1 mM malate 
1 mM oxaloacetate 
1 mM succinate 
1 mM malate + 
10 mM cY-cyano-3- 
hydroxycinnamate 
1 mM malate + 10 mM 
butylmalonate 
1 mM pyruvate 
10 mM butylmalonate 
10 mM butylmalonate 
1 mM citrate 
1 mM phosphate 
13.27 + 1.42 (4) 
12.19 f 1.34 (6) 
11.7 i 1.14 (3) 
11.79 * 1.58 (4) 
12.04 it 1.28 (6) 
13.97 * 1.6 (3) 
13.2 * 1.22 (3) 
10.23 c 0.44 (3) 
10.65 + 0.10 (3) 
10.65 i 0.10 (3) 
10.65 c 0.10 (3) 
12.25 k 1.42 (2) 
13.83 + 0.33 (3) 
13.23 f 1.41 (4) 98.7 f 1.7 (4) 
7.35 f 1.50* (6) 61.2 r 1.02+ (6) 
11.02 f 2.68 (3) 99.6 + 9.4 (6) 
12.35 f 1.96 (4) 104.3 k 4.2 (4) 
7.11 k 1.23** (6) 59.5 + 11.2+ (6) 
9.92 f 0.38 (3) 72.5 k 6.2t (3) 
8.18 ? 1.16* (3) 64.6 .+ 14.5 (3) 
10.58 f 0.17 (3) 98.4 f 8.8 (3) 
6.85 * 1.08* (3) 64.3 + lot (3) 
5.56 f 1.19** (3) 52.1 + 1.02+ (3) 
7.83 + 0.32** (3) 73.5 r 2.82t (3) 
11.86 f 1.49 (2) 97.9 t 2.1 3 2 + 0 2 3 5 5-+ 1 71 ::i 
Mitochondria (0.8 mg/protein) which had accumulated [2-‘4C]pyruvate were suspended in 5 ml of medium 
2 (see Methods) with or without stated additions, at 20°C. Mitochondria were separated from the medium by 
filtration after 10 s. Data are means f S.E.M. and in parenthesis the numbers of mitochondrial preparations. 
*p <0.05, **p <O.Ol; for difference of mean mitochondrial [2-‘4C]pyruvate content before and after 10 s 
incubation. 
tn <0.05; ‘p <O.Ol for difference from 100 of mean percentage residual mitochondrial [2-!‘C] pyruvate 
after 10 s incubation. 
pyruvate itself due to increased glycolytic flux after 
glucagon injection. In experiment 3 we have 
attempted to minimize contributions from these 
factors by starving the rats for 24 h which abolished 
the glucose mobilization due to glucagon and would 
be expected to increase the palmitoyl-1-carnitine 
content in the control mitochondria. Inclusion of 
malate in the preincubation medium would also be 
expected to minimize any pre-existing difference in 
the concentration of this ion between the two mito- 
chondrial populations. Since the magnitude of the 
glucagon effect on pyruvate uptake in experiment 3 
was unchanged it appears that mitochondrial accumula- 
tion in vivo of either or all of the three anions- 
pyruvate, palmitoyl-1-carnitine or malate did not in 
fact contribute to the effect observed subsequently 
in vitro. It still remains possible that another so far 
unidentified counter ion was responsible. A difference 
in the pH gradient of the isolated mitochondria from 
glucagon injected rats compared to controls (under 
our conditions) seems unlikely since utilization of all 
physiological substrates was blocked during preincuba- 
tion and the only energy source provided was the 
ascorbate/tetramethylphenylenediamine couple. 
Whatever the precise mechanism of this effect of 
glucagon on mitochondrial pyruvate transport it 
appears to involve the mobility of the pyruvate 
carrier in the mitochondrial membrane (I’,,) rather 
than its affinity for pyruvate (KM) (table 4). The KM 
value obtained was higher than that reported by 
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